The Use of Omalizumab in Chronic Urticaria: Available Data and Future Aspects of Anti-IgE Treatment
Chronic urticaria (CU) defined as repeatedly occurred itchy wheals and/or angioedema for at least 6 weeks. Due to the unpredictability, recurrent and disabling symptoms, and a considerably impaired quality of life, effective and tolerable treatment for CU patients is crucial. Almost a half of patien...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/76128 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: The Use of Omalizumab in Chronic Urticaria: Available Data and Future Aspects of Anti-IgE Treatment
- The Role of Anti-IgE Antibodies in Urticaria
- Chronic Spontaneous Urticaria – Diagnosis and Management
- Treatment of Allergic Rhinitis: Anticholinergics, Glucocorticotherapy, Leukotriene Antagonists, Omalizumab and Specific-Allergen Immunotherapy
- Chronic urticaria in children: epidemiology, diagnosis, and management
- Asma bronquial: IgE factor de riesgo en niños sanos
- IgE: Utilidad en el diagnóstico de la enfermedad alérgica